Buzz Stocks: Express, Inc., Oculus Innovative Sciences, Inc., and Fitbit Inc

Today's stocks to watch in the news include Express, Inc. (NYSE:EXPR), Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), and Fitbit Inc (NYSE:FIT)

Aug 24, 2016 at 9:24 AM
facebook X logo linkedin

Dow futures are cautiously higher this morning, as traders await Friday's big central bank speech. Meanwhile, among specific equities in focus are retailer Express, Inc. (NYSE:EXPR), biotech Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), and wearable tech stock Fitbit Inc (NYSE:FIT).

  • EXPR is set to lose roughly one-fifth of its value when the market opens, after the company slashed its full-year outlook in light of weak store traffic. The projected move would put the stock in territory not seen since February 2015, after the shares closed Tuesday at $16.03. While the pending sell-off matches options traders' bearish expectations, some analysts may start to adjust their outlooks. For example, five of the 11 brokerage firms covering EXPR say it's a "strong buy," and none recommend selling the stock. Just this morning, though, Deutsche Bank downgraded the stock to "hold" from "buy," and lowered its price target to $12 from $19.
  • OCLS is looking to take advantage of a favorable Food and Drug Administration (FDA) ruling, with the stock up 13% in electronic trading. More specifically, the FDA approved the drugmaker's post-dermal procedures treatment, which it'll begin marketing in the U.S. next March. It's been a rough year for the penny stock, as it's lost almost 31% of its value year-to-date, and closed last night at $3.98. Meanwhile, a recent batch of short sellers will likely be kicking themselves, seeing as short interest on Oculus Innovative Sciences, Inc. popped by nearly 25% in the last reporting period. 
  • FIT is up 3% in pre-market trading, after a U.S. International Trade Commission judge ruled the company did not steal classified information from fellow wearable tech firm Jawbone. Fitbit Inc rallied on Tuesday, as well, before settling at $14.88, as the stock looks to live up to analysts' lofty expectations. That is, despite FIT's 49.7% drop in 2016, more than half the analysts covering the stock recommend buying it, with not a single "sell" rating on the board, while its average 12-month price target stands at $21.38 -- territory not explored since early January. 

Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI